inhumane
发表于 2025-3-30 08:28:18
http://reply.papertrans.cn/43/4256/425562/425562_51.png
Spongy-Bone
发表于 2025-3-30 12:26:33
http://reply.papertrans.cn/43/4256/425562/425562_52.png
pacifist
发表于 2025-3-30 20:17:41
Alan E. Lichtins to the determination of the human excretion profile of drugs, the stability of drugs in wastewater, the dynamics of the population, sewage epidemiology provides several opportunities, including a cost-effective, comprehensive, noninvasive, and nearly real-time measure of trends of drug use over time.
Fortuitous
发表于 2025-3-30 21:07:05
http://reply.papertrans.cn/43/4256/425562/425562_54.png
MARS
发表于 2025-3-31 04:15:47
http://reply.papertrans.cn/43/4256/425562/425562_55.png
jaundiced
发表于 2025-3-31 06:55:46
http://reply.papertrans.cn/43/4256/425562/425562_56.png
漂亮才会豪华
发表于 2025-3-31 10:59:58
Early-Acting Hematopoietic Growth Factors: Biology and Clinical Experiencem for manipulating other stem cell based tissues. This chapter reviews the preclinical knowledge accumulated over ∼40 years, since the discovery of the first such growth factor, and the clinical applications of those that, upon testing in humans, ultimately gained regulatory approval for the treatment of various hematological diseases.
言行自由
发表于 2025-3-31 13:29:57
Meta-Analysis of Randomized Controlled Trials of Granulocyte Colony-Stimulating Factor Prophylaxis igroups was observed despite the allowed use of secondary G-CSF prophylaxis after an initial occurrence of FN in the control group (. < 0.001). Several additional clinical trials of prophylactic G-CSF in patients with various malignancies receiving different treatment regimens have been reported .
千篇一律
发表于 2025-3-31 21:06:17
Granulocyte Colony-Stimulating Factors and Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrond children consistently demonstrating the impact of these agents on neutropenia and its complications . Clinical practice guidelines have been put forward by the American Society of Clinical Oncology and other professional organizations for the use of these agents .